Date:This live activity will take place on October 8, 2019 from 1:00 pm – 2:00 pm ET. Participants must attend this live activity in its entirety to receive live credit.
This live activity must be completed by November 22, 2019 at 11:59 pm ET. No exceptions or extensions permitted. *
Cost: Free for ASCP Members, $10 for Non-Members. Can't make the live program, the on-demand version will available to ASCP learners and posted on November 1, 2019.
*If you are looking for BCGP registration, please click here**
To Purchase: Make sure you are signed into you ASCP account. For paid courses, click “Buy-Now” and complete the checkout process. For free courses, click “Launch”. This course will now be listed in your “My Learning” tab inside “Active”.
To Pre-register: Launch the course. In the pop-up window, click the registration on the left. It may take 3-5 seconds to load. When successful, you will see a dialog for when the webinar will start and shortly receive an email confirmation. Check your SPAM folder if you do not receive the link to your email. You can also return to this course on the day of the registration and "Launch" the activity from here.
To Join Webinar: Launch the course. In the pop-up window, click the registration on the left. It may take 3-5 seconds to load. When successful, you should receive a download for GoToWebinar to start the webinar. Alternatively, you can also join the webinar from the email reminders or confirmation you should have received if you preregistered. To join from a mobile device, you should follow the “Join Webinar” link from the email reminders or confirmation. You may be asked to install an app to join the webinar.
Speaker:
Mary Beth O’Connell, PharmD, BCPS, FASHP, FCCP, FNAP, AGSF
Professor
Wayne State University
Financial Disclosure:
Mary
Beth O’Connell discloses no relevant financial conflicts of interest with
regard to this activity.
Target Audience:
This activity is
intended for pharmacists who are interested in:New Osteoporosis Medications and
Preventing Medication-Induced Osteoporosis for the Senior Patient
Learning Objectives:
At the conclusion of this Application-Based activity, participants should be
able to:
- Integrate abaloparatide and romosozumab into osteoporosis treatment regimens.
- Identify, prevent and treat glucocorticoid induced osteoporosis.
- Adjust medications that can increase osteoporosis and osteoporotic fractures.
The American Society of Consultant Pharmacists (ASCP) is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
UAN: 0203-0000-19-054-L01-P
Credits: 1.5 Contact Hours (1 hour of live content, 0.5 hours for post-test assessment)
Expiration: November 22, 2019 by 11:59 pm ET
*A recorded version will be posted by October 18, 2019 with UAN:0203-0000-19-054-H01-P
*This activity is NOT FL Consultant Approved
How to Earn Credit:
Post-Test:
You will have unlimited attempts to achieve a 70% or higher on the post-test assessment.
CPE Credit: PLEASE NOTE THAT YOU MUST COMPLETE BOTH THE POST TEST AND THE EVALUATION ASSESSMENT BY NOVEMBER 22, 2019 AT 11:59 PM ET TO EARN CREDIT FOR THIS WEBINAR. ASCP reports CPE attainment to ACPE and NABP via the CPE Monitor system. The course should be posted within 24-48 hours of evaluation completion. It is the responsibility of the participant to provide their correct date of birth (MMDD format) and NABP e-Profile ID on their member or guest profile on the ASCP Website.
Please see computer hardware/software requirements here.